rot in Medical Technology

First Patient of NOTES Investigational Device Exemption (IDE) Study Successfully Treated With Ethicon Endo-Surgery Devices

...The content of the investigational Ethicon Endo-Surgery Toolbox includes: Tissue Apposition System Steerable Flex Trocar with rotary Access Needle Flexible Bipolar Hemostasis Forceps Flexible Maryland Dissector Articulating Hook Knife Articulating...

Leading Experts Endorse Bioheart's Muscle Stem Cell MyoCell Therapy

...uscle and they do excrete fatigue resistant proteins similar to the heart muscle protein." Dr. HJ Duckers, Interventional Cardiologist, Thoraxcenter, rotterdam discussed the history of the Bioheart trials in Europe to date and added that "the myoblast therapy is at this time point the only stem cell th...

GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting

... President Todd H. Stroger and the Commissioners of Cook County; the Cook County Health and Hospitals Systems Board ("Health System"); and the Ruth M. rothstein's CORE Center's Foundation ("Foundation"), which was founded by Cook County, Illinois and Rush University Medical Center. We hope this effor...

Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial

...tform over the next several years that address patient needs and expand the addressable market for this innovative technology. These products include: rotator cuff repair, wound care applications and abdominal wall reconstruction; Osteotech estimates that this expanded addressable market opportunity wil...

Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox

...The content of the investigational Ethicon Endo-Surgery Toolbox includes: Tissue Apposition System Steerable Flex Trocar with rotary Access Needle Flexible Bipolar Hemostasis Forceps Flexible Maryland Dissector Articulating Hook Knife Articulating...

IMPACT Study Showed Longer Valcyte(R) (valganciclovir hydrochloride tablets) Treatment Demonstrated Better Protection Against Cytomegalovirus (CMV) Disease One Year Post-Transplant

...he time period during which patients are the most immunosuppressed might lead to less CMV disease and better patient outcomes." The IM proved P rotection A gainst C ytomegalovirus in T ransplant (IMPACT) study showed that 200-day Valcyte prophylaxis significantly reduced the proportion of pati...

vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque

...Shield as a prophylactic treatment for non-flow-limiting vulnerable plaques. The SECRITT I trial is sponsored and conducted by Erasmus University in rotterdam. The 6-month follow-up exam was performed on May 20 by an interventional cardiology team led by Professor Patrick Serruys, the principal invest...

FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension

...orts led by Eli Lilly & Company, we are thrilled to make available an effective, convenient and economical therapy for PAH patients," said Martine rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "The FDA's action in approving once-a-day ADCIRCA is a big plus for all thre...

Terumo Heart, Inc. Reaches Clinical Milestone as the 100th Patient Worldwide Receives the DuraHeart(TM) Left Ventricular Assist System

... The DuraHeart LVAS is the first, third-generation rotary blood pump designed for long-term patient support that incorporates a centrifugal flow rotary pump with an active magnetically levitated imp...so when the motor spins, it causes the impeller to rotate and pump blood from the heart to the body. In...

Fovea Reports Positive Results with Prednisporin(TM) in Persistent Allergic Conjunctivitis

...h industrial partners like Dyax, Novartis, Genzyme and CombinatoRx, as well as with academic teams, like the Inserm unit U968 (Vision Institute), the rothschild Ophthalmological Foundation or the Johns Hopkins University . For more information, please visit www.fovea-pharma.com About Or...

Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study

...based technology used primarily by interventional cardiologists, radiologists, and vascular surgeons for the treatment of PAD. The device uses a small rotating blade to shave away plaque from inside the artery. As it is excised, the plaque collects in the tip of the device and then is removed from the p...

Progress Against Malaria and Other Infectious Diseases Among Highlights at Annual Vaccine Conference

...nt of the Charles Merieux Award. Dr. Offit, who is also a professor of pediatrics at the University of Pennsylvania Medical School, co-developed the rotavirus vaccine manufactured by Merck & Co., Inc. He has also been a strong defender of vaccines. Dr. Offit, who will receive the award at an ...

Study Data Show Positive European Experience With DuraHeart Left Ventricular Assist Device for Advanced Stage Heart Failure Patients

...The DuraHeart System is the first third-generation rotary blood pump designed for long-term patient support that incorporates a centrifugal flow rotary pump with an active magnetically levitated imp...so when the motor spins, it causes the impeller to rotate and pump blood from the heart to the body. In ...

New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management

... "More comprehensive treatment is often needed in certain patients with mixed dyslipidemia to help reach targets for all three key lipids," said Eli roth, M.D., University of Cincinnati College of Medicine, and Sterling Research Group, Cincinnati, Ohio. "The results from this study are encouraging ...

Abbott's Market-Leading XIENCE V(R) Shows Increasing Clinical Advantages Over TAXUS(R) Express2(TM)/TAXUS(R) Liberte(TM) Between Two and Three Years

...AXUS out to three years," said Patrick W. Serruys, M.D., Ph.D., professor of Interventional Cardiology at Thoraxcentre, Erasmus University Hospital, rotterdam, the Netherlands, and principal investigator of the SPIRIT II clinical trial. "What's even more impressive is that the clinical differences bet...

Abbott Advances Its Revolutionary Fully Bioabsorbable Drug Eluting Stent With Initiation of Next Phase of Clinical Trial

...stents were created," said Patrick W. Serruys, M.D., Ph.D., professor of interventional cardiology at the Thoraxcentre, Erasmus University Hospital, rotterdam, and principal investigator of the ABSORB trial. "Now we have the fourth revolution in interventional cardiology technology, and patient outcom...

David Feldman, M.D. Appointed Co-Principal Investigator of DuraHeart(TM) Left Ventricular Assist System U.S. Clinical Trial

...sors to keep it centered within the blood chamber. Magnets in the motor couple to the impeller so that when the motor spins, it causes the impeller to rotate and pump blood from the heart to the body. Once the DuraHeart is running, blood flows from the left ventricle, through the pump and directly to t...

New, Published GELNIQUE Data Show Efficacy, Convenience and Excellent Tolerability

...gh the skin over a 24-hour period. A 1- gram (approx. 1 mL) daily dose delivers about 4 mg oxybutynin each day. Patients applied GELNIQUE each day to rotating sites on the abdomen, upper arm or shoulder and thigh. By week 12, the mean number of episodes of urinary incontinence, the study's prima...

The Lancet Publishes Two-Year Results of Abbott's Fully Bioabsorbable Drug Eluting Stent

...ased stent implants," said Patrick W. Serruys, M.D., Ph.D., professor of interventional cardiology at the Thoraxcentre, Erasmus University Hospital, rotterdam, the Netherlands; lead author of The Lancet publication; and co-principal investigator of the first phase of the ABSORB trial. "This bioabsor...

Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient

...The DuraHeart System is the first third-generation rotary blood pump designed for long-term patient support that incorporates a centrifugal flow rotary pump with an active magnetically levitated imp...so when the motor spins, it causes the impeller to rotate and pump blood from the heart to the body. In...

CyberKnife Radiosurgery for Lung Cancer Sees Increased Interest and Continued Rapid Growth

... as a tool available to the thoracic surgeon while also emphasizing the critical role surgeons play in the CyberKnife treatment process. Jack A. roth, M.D., Professor of Thoracic and Cardiovascular Surgery and Johnson Distinguished Chair at the University of Texas M. D. Anderson Cancer Center an...

Applying Clinical Findings to the Practice of Medicine

...nt for the following areas of musculoskeletal health: Torn rotator cuffs ( http://orthoinfo.aaos.org/topic.cfm?topic=A00064 ) O...search related directly to musculoskeletal disease or injury. Torn rotator cuffs The 2009 Young Investigator Award, given to outstanding auth...

American Academy Of Orthopaedic Surgeons 2009 Annual Meeting 'Highlights and Hot Topics'

...n distant relatives who have suffered tears to the rotator cuff, the muscles and tendons that hold the t...ers on the same family tree to also develop a torn rotator cuff. This risk extends out to third-cousin ...und that if any relative, even distant, suffered a rotator cuff injury, there was a greater likelihood o...

Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix

...ed tissue products over the next several years that address patient needs and expand the addressable market for this innovative technology, including: rotator cuff repair, wound care applications and abdominal wall reconstruction. About DuraTech(TM) BioRegeneration Matrix Utilizing Osteotec...

MGuard(TM) Coronary Stent System Approved in Israel

...SVG. Martin Leon MD and Chaim Lotan MD will chair the meeting where additional speakers include key world renowned interventional cardiologists Martin rothman MD and Dariusz Dudek MD. In the past year, MGuard(TM) has been successfully implanted in complex lesions in live cases at major intervent...

Clinical Trial Results on the Sleep-Promoting Effects of Vanda Pharmaceuticals' Circadian Regulator Tasimelteon (VEC-162) Published in The Lancet

...ood as well as cardiovascular and metabolic processes.(3)(4) Circadian rhythm sleep disorders include insomnia associated with shift work (overnight, rotating and early riser), travel across time zones, delayed sleep phase syndrome, advanced phase syndrome and the non-24-hour sleep-wake syndrome in the...

Atrial Fibrillation Found to be Common in Patients With Atherothrombosis, Increases Risk of Cardiovascular Death, Heart Attack and Stroke

... use of anticoagulants (53.1% vs 7.1%). References 1. Goto S, Bhatt DL, rother J, Alberts M, Hill MD, Ikeda Y, et al. Prevalence, clinical profile, an...1(4):786 e1-10. 4. Steg PG, Bhatt DL, Wilson PWF, D'Agostino R, Ohman EM, rother J, et al. One-year cardiovascular event rates in outpatients with ather...

Nerviano Medical Sciences Invited by EORTC-NCI-AACR to Present the State-of-the-Art of Aurora

...ing clinical Phase II trials in solid tumours and blood cancers at some of the most widely acknowledged international clinics: Erasmus Medical Center, rotterdam, Policlinico Gemelli, Rome, Gustave Roussy, Villejuif, France, University of California, Los Angeles (UCLA) and University of California, San F...

Five-Year Data Confirm That Early Treatment with Betaseron(R) at First Sign of Disease Can Delay Progression to MS

...epression. Injection-site necrosis has been reported in four percent of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Wa...

New Data Presented at WCTRIMS* Supports the Importance of Early and Sustained Treatment with Betaseron(R)

...epression. Injection-site necrosis has been reported in four percent of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Wa...

Volcano's VH(R) IVUS Technology Used in Imaging Study of GlaxoSmithKline's Novel Investigational Compound, Darapladib

...es that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(R) IVUS tissue characterization and ChromaFlo(R). Volcano also provides...

New Genes Found for Inflammatory Bowel Disease in Children

...lvatore Cucchiara, M.D., Ph.D., of Sapienza University, Rome, Italy; and Vito Annese, M.D., of "Casa Sollievo della Sofferenza" Hospital, San Giovanni rotondo, Italy. About The Children's Hospital of Philadelphia: The Children's Hospital of Philadelphia was founded in 1855 as the nation's first pediat...

CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System

...n Intensity Modulated Radiotherapy (IMRT) treatment planning system. Allegheny General Hospital in Pittsburgh, Pennsylvania, Erasmus Medical Center in rotterdam, Netherlands, and Froedtert Memorial Lutheran Hospital in Milwaukee, Wisconsin, have all begun producing treatment plans with the application. ...

Image Guided Radiation Therapy in Latham, NY. Now Fighting Cancer Using Fast and Precise RapidArc(TM) Radiotherapy Technology

...patient's tumor. These treatments can be completed more quickly than conventional image guide IMRT because they are delivered with a single continuous rotation of the radiotherapy machine around the patient rather than treating the tumor from fixed positions. Donald Shorkey, 71, an early-stage prostat...

Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery

... long-acting, site specific, non-opioid drug candidate for the management of acute pain in patients undergoing arthroscopic shoulder surgery involving rotator cuff repair. Adlea is currently in two pivotal Phase 3 trials in the U.S.: one in total knee replacement surgeries and one in bunionectomy surg...

Long-Term Pegylated Interferon Alfa-2b Therapy in Stage III Melanoma Demonstrated Significant and Sustained Impact on Relapse-Free Survival

...urvival," said Alexander Eggermont, M.D., Ph.D., lead investigator and head of the department of surgical oncology, Erasmus University Medical Center, rotterdam, The Netherlands. Among the most significant findings in the study, at 3.8 years median follow up, the risk of recurrence or death was reduce...

'Hibernation-On-Demand' Drug Hydrogen Sulfide Significantly Improves Survival After Extreme Blood Loss

...ydrogen sulfide, or H2S -- the molecule that gives rotten eggs their sulfurous stench -- significantly i...treme blood loss in rats. Cell biologist Mark B. roth, Ph.D., and colleagues in the Basic Sciences Div...ccident or on the battlefield," said senior author roth. "These findings have obvious implications for t...

Patient Receives vProtect(TM) Luminal Shield in First-Ever Vulnerable Plaque Clinical Trial

...e Treatment of Potentially Life Threatening Vulnerable Plaques rotTERDAM, Netherlands and DOYLESTOWN, Pa., June 30 /PRNewswire/ -- An interve...ing (LAD) coronary artery of a 64-year-old man at Erasmus Medical Center in rotterdam. This case marks the start of a pilot study, known as SECRITT I, des...

New Drug Application for Inhaled Treprostinil Submitted to the U.S. Food and Drug Administration

... an action letter is issued. "We believe that an inhaled formulation of treprostinil will be a very desirable option for PAH patients," said Martine rothblatt, Ph.D., United Therapeutics' Chairman and Chief Executive Officer. "The completion of the NDA filing is a huge milestone in United Therapeutics...

Phase III Data Show Vanda Pharmaceuticals' Tasimelteon (VEC-162) Significantly Improves Sleep in Patients with Chronic Insomnia

...2008. 6. D'Alonzo GE, Krachman SL. Circadian rhythm sleep disorders. JAOA. 2000;100(8):S15-21. 7. Drake CL, Roehrs T, Richardson G, Walsh JK, roth T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep. 2004;27:1453-62. 8. Carney PR, ...